Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2018 09:00 ET | Source: TESARO, Inc.

TESARO Summarizes TSR-042 Clinical Data Presented at AACR

Activity of TSR-042 (anti-PD-1 antibody) monotherapy demonstrated in patients with MSI-high endometrial and non-small cell lung cancers Data support unique and convenient dosing scheduleRegulatory...
April 27, 2017 08:15 ET | Source: TESARO, Inc.

TESARO Initiates Registrational Development Program for Anti-PD-1 Antibody TSR-042

TSR-042 is the first TESARO immuno-oncology candidate to enter a registration programOngoing clinical trial expanded to enroll patients with endometrial cancerPatient-centric administration...